Dr. Swiecicki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
B1 floor Cancer Recp C
Ann Arbor, MI 48109Phone+1 734-647-8902
Summary
- Dr. Paul Swiecicki is an oncologist in Ann Arbor, MI and is affiliated with Michigan Medicine. He received his medical degree from Michigan State University College of Human Medicine and has been in practice 8 years. He specializes in head & neck cancer.
Education & Training
- University of MichiganFellowship, Hematology and Medical Oncology, 2014 - 2017
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2011 - 2014
- Michigan State University College of Human MedicineClass of 2011, MD
Certifications & Licensure
- MI State Medical License 2014 - 2027
- MN State Medical License 2012 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer Start of enrollment: 2017 Apr 27
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsFollow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collection.Donna M Edwards, Laila A Gharzai, Weilin Wang, Charles Mayo, Krithika Suresh
Head & Neck. 2024-11-01 - Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer.Paul L Swiecicki, Emrullah Yilmaz, Ari Joseph Rosenberg, Takao Fujisawa, Justine Yang Bruce
Journal of Clinical Oncology. 2024-10-31 - Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer.William J Benjamin, Allen L Feng, Molly Heft Neal, Emily Bellile, Keith A Casper
Oral Oncology. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: